Brief: Biovica's Divitum Clinical Validation Data In Biomarkers

Biovica International AB

31/01/2023 08:59

Jan 31 (Reuters) - Biovica International AB
 BIOVICb.ST :
    * DIVITUM® TKA CLINICAL VALIDATION DATA PUBLISHED IN
BIOMARKERS
    * BIOVICA INTERNATIONAL AB - RESULTS SUPPORT USE OF DIVITUM
TKA
WHEN MONITORING METASTATIC BREAST CANCER PATIENTS AND WERE
FOUNDATION LEADING TO FDA CLEARANCE OF ASSAY

Source text for Eikon:  ID:nMFN9vDPN2 
Further company coverage:  BIOVICb.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))